Sepsis research and the poorest of the poor

The Lancet Infectious Diseases

Volumn 15, Issue 5, 2015, Pages 501-503

  Riviello, Elisabeth D ^a,b   Sugira, Vincent ^b   Twagirumugabe, Theogene ^b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF RWANDA   (Rwanda)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC RESISTANCE; CLINICAL TRIAL (TOPIC); HEALTH CARE PRACTICE; HEALTH CARE SYSTEM; HUMAN; INCOME; INTENSIVE CARE; LOWEST INCOME GROUP; LUNG EDEMA; MORTALITY; NONHUMAN; NOTE; PRIORITY JOURNAL; SEPSIS; SEPTIC SHOCK; VENTILATOR ASSOCIATED PNEUMONIA; MEDICAL RESEARCH; MOLECULARLY TARGETED THERAPY; TRENDS;

ANTIINFECTIVE AGENT; IMMUNOLOGIC FACTOR;

ANTI-BACTERIAL AGENTS; BIOMEDICAL RESEARCH; HUMANS; IMMUNOLOGIC FACTORS; MOLECULAR TARGETED THERAPY; SEPSIS;

EID: 84928122881     PISSN: 14733099     EISSN: 14744457     Source Type: Journal    
DOI: 10.1016/S1473-3099(15)70148-9     Document Type: Note

References (15)

1. Cohen J, Vincent J-L, Adhikari NKJ, et al. Sepsis: a roadmap for future research. Lancet Infect Dis 2015, 15:581-614.
2. Adhikari NK, Fowler RA, Bhagwanjee S, Rubenfeld GD Critical care and the global burden of critical illness in adults. Lancet 2010, 376:1339-1346.
3. Kwizera A, Dunser M, Nakibuuka J National intensive care unit bed capacity and ICU patient characteristics in a low income country. BMC Res Notes 2012, 5:475.
4. Gaieski DF, Edwards JM, Kallan MJ, Carr BG Benchmarking the incidence and mortality of severe sepsis in the United States. Crit Care Med 2013, 41:1167-1174.
5. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2015, 385:117-171. GBD 2013 Mortality and Causes of Death Collaborators.
6. Levy MM, Rhodes A, Phillips GS, et al. Surviving sepsis campaign: association between performance metrics and outcomes in a 7 5-year study. Crit Care Med 2015, 43:3-12.
7. Kim JY, Farmer P, Porter ME Redefining global health-care delivery. Lancet 2013, 382:1060-1069.
8. Maitland K, Kiguli S, Opoka RO, et al. Mortality after fluid bolus in African children with severe infection. N Engl J Med 2011, 364:2483-2495.
9. Andrews B, Muchemwa L, Kelly P, Lakhi S, Heimburger DC, Bernard GR Simplified severe sepsis protocol: a randomized controlled trial of modified early goal-directed therapy in Zambia. Crit Care Med 2014, 42:2315-2324.
10. Yealy DM, Kellum JA, Huang DT, et al. A randomized trial of protocol-based care for early septic shock. N Engl J Med 2014, 370:1683-1693.
11. Riviello ED Improving outcomes for severe sepsis in Africa: one step closer. Crit Care Med 2014, 42:2439-2440.
12. Cheng AC, West TE, Limmathurotsakul D, Peacock SJ Strategies to reduce mortality from bacterial sepsis in adults in developing countries. PLoS Med 2008, 5:e175.
13. Ntirenganya C, Manzi O, Muvunyi CM, Ogbuagu O High prevalence of antimicrobial resistance among common bacterial isolates in a tertiary healthcare facility in Rwanda. Am J Trop Med Hyg 2015, published online Feb 2. 10.4269/ajtmh.14-0607.
14. Bah EI, Lamah MC, Fletcher T, et al. Clinical presentation of patients with Ebola virus disease in Conakry, Guinea. N Engl J Med 2015, 372:40-47.
15. Weiser TG, Regenbogen SE, Thompson KD, et al. An estimation of the global volume of surgery: a modelling strategy based on available data. Lancet 2008, 372:139-144.